EP2328601
Efnasamsetningar sem innihalda línaklótíð til gjafar um munn
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.8.2009EP published:
22.1.2020EP application number:
09789142.8
EP translation filed:
23.3.2020Grant published:
15.4.2020EPO information:
European Patent Register
Max expiry date:
13.8.2029Expiry date:
13.8.2026Next due date:
31.8.2026
Title:
LINACLOTIDE-CONTAINING FORMULATIONS FOR ORAL ADMINISTRATION
Timeline
Today
14.8.2009EP application
22.1.2020EP Publication
23.3.2020Translation submitted
15.4.2020Registration published
13.8.2026Expires
Owner
Name:
Ironwood Pharmaceuticals, Inc.Address:
301 Binney Street, Cambridge, Massachusetts 02142, US
Inventor
Name:
FRETZEN, AngelikaAddress:
Somerville MA 02143, US
Name:
WITOWSKI, StevenAddress:
Melrose MA 02176, US
Name:
GROSSI, AlfredoAddress:
Somerville MA 02145, US
Name:
ZHAO, HongAddress:
Somerville MA 02143, US
Name:
DEDHIYA, MahendraAddress:
Pomona NY 10970-3219, US
Name:
MO, YunAddress:
Commack NY 11725, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
89422 PDate:
15.8.2008Country:
US
Number:
273332 PDate:
3.8.2009Country:
US
Number:
231725 PDate:
6.8.2009Country:
US
Classification
Categories:
A61K 38/10, A61K 9/50, A61K 9/16, A61K 9/20, A61K 9/48, A61J 3/00
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 8.7.2020
Expires: 13.8.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 12.7.2021
Expires: 13.8.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 5.7.2022
Expires: 13.8.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 11.7.2023
Expires: 13.8.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 9.7.2024
Expires: 13.8.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 7.8.2025
Expires: 13.8.2026
Payer: Árnason Faktor ehf.